BUSINESS Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer Tuesday, July 21, 2026 · allogenetics gmbh Source Summary Allogenetics today announced the appointment of Jeroen Rovers, MD, PhD, as Chief Medical Officer. Advertisement Read Original Article → Related Dispatches [US] · Jul 21 Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026 [US] · Jul 21 Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease [US] · Jul 21 RADCOM to Report Second Quarter 2026 Results on Wednesday, August 12, 2026